Summary
Glycosylation is necessary for HIV-1 gp120 to attain a functional conformation, and individual N-linked glycans of gp120 are important, but not essential, for replication of HIV-1 in cell culture. We have constructed a mutant HIV-1 infectious clone lacking a signal for N-linked glycosylation in the V1-loop of HIV-1 gp120. Lack of an N-linked glycan was verified by a mobility enhancement of mutant gp120 in SDS-gel electrophoresis. The mutated virus showed no differences in either gp120 content per infectious unit or infectivity, indicating that the N-linked glycan was neither essential nor affecting viral infectivity in cell culture. We found that the mutated virus lacking an N-linked glycan in the V1-loop of gp120 was more resistant to neutralization by monoclonal antibodies to the V3-loop and neutralization by soluble recombinant CD4 (sCD4). Both viruses were equally well neutralized by ConA and a conformation dependent human antibody IAM-2G12. This suggests that the N-linked glycan in the V1-loop modulates the three-dimensional conformation of gp120, without changing the overall functional integrity of the molecule.
Similar content being viewed by others
References
Back KTN, Smit L, De Jong J, Keulen W, Schutten M, Goudsmit J, Tersmitte M (1994) An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. Virology 189: 431–438
Bolmstedt A, Olofsson S, Sjögren Jansson E, Jeansson S, Sjöblom I, Åkerblom L, Hansen JE, Hu SL (1992) Carbohydrate determinant NeuAcGal beta (1–4) of N-linked glycans modulate the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120. J Gen Virol 73: 3099–3105
Davis DB, Dulbecco R, Eisen EH, Ginsberg SH (1980) Microbiology, 3rd ed. Harper and Row, Pennsylvania
Fenouillet E, Gluckman JC, Bahraoui E (1990) Role of N-linked glycans of human immunodeficiency virus type 1. J Virol 64: 2841–2848
Hansen J-ES, Nielsen C, Arendrup A, Olofsson S, Mathiesen L, Nielsen JO, Clausen H (1991) Broadly neutralizing antibodies targeted to mucintype carbohydrate epitopes of human immunodeficiency virus. J Virol 65: 6461–6467
Harada S, Koyanagi Y, Yamamoto N (1985) Infection of HTLV-III/LAV in HTLV-1-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563–566
Hemming A, Lundberg L, Olofsson S (1989) A strategy simplifying site directed mutagenesis in the CD4-binding region of HIV gp120. Arch Virol 107: 301–305
Hwang SS, Boyle TJ, Lyerly HK, Cullen BR (1992) Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science 257: 535–537
Koito A, Harrowe G, Levy JA, Cheng-Meyer C (1994) Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. J Virol 68: 2253–2259
Lasky LA, Nakamura G, Smith DH, Fennie C, Shimasaki C, Patzer E, Berman P, Gregory T, Capon DJ (1987) Delineation of a region of human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50: 975–985
Lee WR, Syu WJ, Matsuda M, Tan S, Wolf A, Essex M, Lee TH (1992) Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 89: 2213–2217
Leonard CK, Spellman WM, Riddle L, Harris RJ, Thomas NJ, Gregory JT (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylations sites of type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp 120) expressed in chinese hamster ovary cells. J Biol Chem 265: 10737–10382
McKeating J, Balfe P, Balfe P, Clapham P, Weiss RA (1991) Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity. J Virol 65: 4777–4785
Moore JP, Wallace LA, Follet EAC, McKeating J (1989) An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. AIDS 3: 155–163
Moore JP, Thali M, Jameson BA, Vignaux F, Lewis GK, Poon SW, Charles M, Fung MS, Sun B, Durda PJ, Åkerblom L, Wahren B, Ho DD, Sattentau QJ, Sodroski J (1993) Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop. J Virol 67: 4785–4796
Nara PL, Garrity RR, Goudsmit J (1991) Neutralization of HIV-1: A paradox of humoral Proportions. FASEB J 5: 2437–2455
Nielsen CM, Bygbjerg IC, Vestergård BF (1987) Detection of HIV antigens in eluates from whole blood collected on filter paper. Lancet i: 566–567
Pollard RS, Rosa DM, Rosa JJ, Wiley CD (1992) Truncated variants of gp120 bind CD4 with high affinity and suggests a minimum CD4 binding region. EMBO J 11: 585–591
Popovic M, Sarngadharan MG, Read E, Gallo RC (1984) Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224: 497–500
Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endopoints. Am J Hyg 27: 493–497
Salahuddin S, Markham P, Wong-Staal F, Franchini G, Kalyanaraman V, Gallo RC (1983) Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 129: 51–64
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, New York
Åkerblom L, Hinkula J, Broliden PA, Mäkitalo B, Friedberger T, Rosen J, Villacres-Eriksson M, Morein B, Wahren B (1990) Neutralizing crossreactive and non-neutralizing antibodies to HIV-1 gp120. AIDS 4: 953–960
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gram, G.J., Hemming, A., Bolmstedt, A. et al. Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. Archives of Virology 139, 253–261 (1994). https://doi.org/10.1007/BF01310789
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01310789